The ISN Amgen International Prize for
Therapeutic Advancement in Nephrology
Call for Nominations
The ISN
Amgen Inc. International Prize
was established in 2003 with the generous support of Amgen to recognize those who have increased the understanding and treatment of kidney disease, through basic or clinical scientific research leading to therapeutic advances.
During the World Congress of Nephrology 2003 in Berlin,
Dr. Barry M. Brenner
of the Harvard Medical School and Director Emeritus of the Renal Division, Brigham and Women’s Hospital, Boston, MA (USA) received $50,000 for establishing the foundations of understanding of the progression of chronic kidney disease and its retardation by blockade of the renin angiotensin system in experimental and clinical studies, leading to major benefit for millions of patients with diabetes, hypertension, and other kidney disease.
The AMGEN International Prize for Therapeutic Advancement of Nephrology recognizes the increased understanding and treatment of kidney disease through basic or clinical scientific research leading to therapeutic advances. The inaugural prize in 2003 was made at the ISN 2003 World Congress in Berlin to Barry M. Brenner, MD of Brigham and Women’s Hospital, and Harvard University, Boston, USA, for establishing the foundations of our understanding of the progression of chronic kidney disease and its retardation by blockade of the renin angiotensin system in experimental and clinical studies leading to major benefit to millions of patients with diabetes, hypertension and other kidney disease.
The recipient of the 2005 Prize will receive $50,000 and a framed certificate with an appropriate citation.Normally, the prize is to be awarded to a single individual. If two individuals are selected, they will share the prize equally. The prize will be awarded without restrictions to nationality, race, religion, or gender. The Advisory Committee representing members of the ISN and AMGEN will recommend recipients of the Prize. Amgen acts in an advisory capacity but is not on the independent selection committee.
To be considered for the Prize, nomination letters must be sent to the following address:
|
|
JOHN H. DIRKS, M.D. CHAIR, AMGEN PRIZE ADVISORY COMMITTEE MASSEY COLLEGE, 4 DEVONSHIRE PLACE TORONTO ON, CANADA, M5S 2E1 FAX: 416 946 3302; EMAIL: [email protected] |
|
|
Deadline for Nominations is September 13, 2004 |
||
Please note, self-nominations will not be considered by the committee.
Nominations Process
A complete nomination package should include:
1. A formal letter of nomination that contains:
(a) Statement declaring whether the award should be made to an individual or whether it should/could be shared with other scientists who may or may not be included in the nomination
(b) Summary of the contributions of the nominee(s)
(c) Description of how and why the work of the nominee(s) represents a major advance in our understanding & treatment of kidney disease through basic or clinical scientific research leading to therapeutic advances & distinguishing those aspects of the work of the nominee(s) that clearly sets it apart from the work of others in the field
2. A full curriculum vitae and list of publications for the nominee(s)
3. At least two letters of support for the nomination
4. The full name and complete contact information for both the nominees and the nominator(s).
The Advisory Committee representing members of the ISN and AMGEN will review all nominations and make the final recommendation for the recipient(s) of the Prize.
The Prize will be presented at the ISN World Congress of Nephrology (WCN) in Singapore, June 26-30, 2005.
This Prize is made possible by the generosity and vision of AMGEN in Thousand Oaks, California
the 2005 ISN Amgen International Prize Call for Nominations in PDF version.
|
|
